(Q38726914)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857998%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

review article

1 reference

title

Constraints and challenges in access to insulin: a global perspective (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857998%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857998%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Margaret Ewen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857998%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Richard Laing

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857998%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

6 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857998%20AND%20SRC:MED&resulttype=core&format=json

The Lancet: Diabetes & Endocrinology

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857998%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857998%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857998%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

275-285

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857998%20AND%20SRC:MED&resulttype=core&format=json

The discovery of insulin: the Rochester, New York, connection

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Diabetes care in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Dispensing patterns and financial costs of glucose-lowering therapies in the UK from 2000 to 2008.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Access to essential drugs in poor countries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Access to essential drugs in poor countries: a lost battle?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

AIDS: patent rights versus patient's rights

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Essential medicines twenty-five years on: closing the access gap

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

WHO's budgetary allocations and burden of disease: a comparative analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

The prevalence and management of diabetes in Thai adults: the international collaborative study of cardiovascular disease in Asia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

How many people inject insulin? UK estimates from 1991 to 2010.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Evolution of insulin patents and market exclusivities in the USA

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Use and out-of-pocket costs of insulin for type 2 diabetes mellitus from 2000 through 2010.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Trends in Medicaid Reimbursements for Insulin From 1991 Through 2014.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

The insulin dilemma in resource-limited countries. A way forward?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Why is there no generic insulin? Historical origins of a modern problem.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

The regulatory framework of biosimilars in the European Union.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Insulin for the world's poorest countries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Looking beyond the issue of access to insulin: what is needed for proper diabetes care in resource poor settings

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Diabetes in Kyrgyzstan: changes between 2002 and 2009.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

The cost of type 1 diabetes: a nationwide multicentre study in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Costs of treatment and complications of adult type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Economic family burden of metabolic control in children and adolescents with type 1 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Economic burden on families of childhood type 1 diabetes in urban Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Lack of insurance hinders Americans' diabetes care

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Doctors worried about threat to supplies of animal insulin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Mixtard 30 - going, going, gone?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Cost containment through pharmaceutical procurement: a Caribbean case study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Access to inhaled corticosteroids is key to improving quality of care for asthma in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

A quiet revolution in global public health: The World Health Organization's Prequalification of Medicines Programme

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

The Diabetes UK Mozambique Twinning Programme. Results of improvements in diabetes care in Mozambique: a reassessment 6 years later using the Rapid Assessment Protocol for Insulin Access

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

On the road to the insulin centenary

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Improving responsiveness of health systems to non-communicable diseases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Informing the 2011 UN Session on Noncommunicable Diseases: applying lessons from the AIDS response

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Global Fund investments in human resources for health: innovation and missed opportunities for health systems strengthening

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Has donor prioritization of HIV/AIDS displaced aid for other health issues?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Expanding access to antiretroviral therapy in sub-saharan Africa: avoiding the pitfalls and dangers, capitalizing on the opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Endemic diabetes in the world's poorest people

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

Developing a hierarchy of needs for Type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

The challenge of diabetes in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900521-5

7 January 2021

10.1016/S2213-8587(15)00521-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26857998%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference